Although CIDR’s (Controlled Intravaginal Drug Release devices, also referred to as PRID’s or Progesterone Releasing Intravaginal Devices) are widely used in the bovine industry in North America, they are not in the equine. This is not because they do not work, but due to a lack of availability of the correct device, as there is no FDA-approved CIDR for the equine although the bovine version marketed as the “Eazi-breed” has been used in an off-label manner.
CIDR’s releasing progesterone are used in the southern hemisphere and the UK, and in fact one specifically designed for use in the equine was developed in New Zealand - the “Cue-Mare”. This model overcomes some of the issues associated with the bovine version being used in the equine, where accidental loss of the device is common.
It should be noted that while CIDR/PRID use in the equine has been demonstrated to have a similar effect to the use of Regumate or other progestins, there is a transient vaginitis associated with it’s use. This does typically clear however by the time the mare enters estrus and breeding commences. While the timing of onset of estrus in the cycling mare is similar to that seen following treatment with Regumate, the same issues apply regarding failures. In an attempt to reduce the potential for these failures, the addition of estrogens to the treatment profile (to create a sort of P&E effect) has been attempted, but although this improved the timing of the onset of the subsequent estrus, it did not “pinpoint” the ovulation to the same degree as is seen with P&E or biorelease altrenogest.
We present the following observations in our course notes:
• CIDR (Controlled Intravaginal Drug Release) devices, aka PRID (progesterone releasing intravaginal device) (Eazi-Breed CIDR Cattle Insert, Pharmacia Animal Health, Kalamazoo MI; Cue-Mare, Duirs PfarmAg, Hamilton NZ) have been demonstrated to assist in hastening the onset of first ovulation (Newcombe JR, Wilsom MC: The use of progesterone releasing intravaginal devices to induce seasonally anœstrus Standardbred mares in Australia. Equine Prac. 1997; 19:13-21)
• This treatment may be combined with an ovulatory stimulant such as Deslorelin or hCG (Newcombe JR, Handler J, Klug E et al: Treatment of transition phase mares with progesterone intravaginally and with deslorelin or hCG to assist ovulations. J. Equine Vet. Sci. 2002; 22:57-64)
• Transient vaginitis and cervicitis is to be expected, although this usually resolves by the time of breeding;
• With mares that respond, rapid onset of œstrus and ovulation within 4-8 days of the removal of the device is to be anticipated;
• Pregnancy rate may be decreased in mares that ovulate >6 days after removal of the CIDR;
• Up to 5% of mares may be expected to expel the device, although the design of the Cue-Mare has largely overcome this problem.
Some additional research is available for viewing in the following paper: Handler J, Schönlieb S, Hoppen H-O, Aurich C.: (2007) Influence of reproductive stage at PRID™ insertion on synchronization of estrus and ovulation in mares; Animal Repro Science 97:3-4; 382-393
Hope this helps.